219 related articles for article (PubMed ID: 18806808)
1. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.
Kempuraj D; Tagen M; Iliopoulou BP; Clemons A; Vasiadi M; Boucher W; House M; Wolfberg A; Theoharides TC
Br J Pharmacol; 2008 Dec; 155(7):1076-84. PubMed ID: 18806808
[TBL] [Abstract][Full Text] [Related]
2. Mercury induces inflammatory mediator release from human mast cells.
Kempuraj D; Asadi S; Zhang B; Manola A; Hogan J; Peterson E; Theoharides TC
J Neuroinflammation; 2010 Mar; 7():20. PubMed ID: 20222982
[TBL] [Abstract][Full Text] [Related]
3. Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis.
Theoharides TC; Kempuraj D; Iliopoulou BP
Adv Exp Med Biol; 2007; 601():423-30. PubMed ID: 17713031
[TBL] [Abstract][Full Text] [Related]
4. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells.
Kempuraj D; Madhappan B; Christodoulou S; Boucher W; Cao J; Papadopoulou N; Cetrulo CL; Theoharides TC
Br J Pharmacol; 2005 Aug; 145(7):934-44. PubMed ID: 15912140
[TBL] [Abstract][Full Text] [Related]
5. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
Weng Z; Patel AB; Panagiotidou S; Theoharides TC
J Allergy Clin Immunol; 2015 Apr; 135(4):1044-1052.e5. PubMed ID: 25498791
[TBL] [Abstract][Full Text] [Related]
6. Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells.
Patel AB; Theoharides TC
J Pharmacol Exp Ther; 2017 Jun; 361(3):462-471. PubMed ID: 28404689
[TBL] [Abstract][Full Text] [Related]
7. Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells.
Asadi S; Zhang B; Weng Z; Angelidou A; Kempuraj D; Alysandratos KD; Theoharides TC
Int J Immunopathol Pharmacol; 2010; 23(4):1015-20. PubMed ID: 21244751
[TBL] [Abstract][Full Text] [Related]
8. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
Bawazeer MA; Theoharides TC
Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
[TBL] [Abstract][Full Text] [Related]
9. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.
Taracanova A; Alevizos M; Karagkouni A; Weng Z; Norwitz E; Conti P; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4002-E4009. PubMed ID: 28461492
[TBL] [Abstract][Full Text] [Related]
10. Human mast cells stimulate activated T cells: implications for multiple sclerosis.
Theoharides TC; Kempuraj D; Kourelis T; Manola A
Ann N Y Acad Sci; 2008 Nov; 1144():74-82. PubMed ID: 19076366
[TBL] [Abstract][Full Text] [Related]
11. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
Vasiadi M; Kalogeromitros D; Kempuraj D; Clemons A; Zhang B; Chliva C; Makris M; Wolfberg A; House M; Theoharides TC
Int Arch Allergy Immunol; 2010; 151(1):38-45. PubMed ID: 19672095
[TBL] [Abstract][Full Text] [Related]
12. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha.
Baram D; Vaday GG; Salamon P; Drucker I; Hershkoviz R; Mekori YA
J Immunol; 2001 Oct; 167(7):4008-16. PubMed ID: 11564820
[TBL] [Abstract][Full Text] [Related]
13. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
14. Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.
Taracanova A; Tsilioni I; Conti P; Norwitz ER; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9381-E9390. PubMed ID: 30232261
[TBL] [Abstract][Full Text] [Related]
15. Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4.
Nelissen S; Vangansewinkel T; Geurts N; Geboes L; Lemmens E; Vidal PM; Lemmens S; Willems L; Boato F; Dooley D; Pehl D; Pejler G; Maurer M; Metz M; Hendrix S
Neurobiol Dis; 2014 Feb; 62():260-72. PubMed ID: 24075853
[TBL] [Abstract][Full Text] [Related]
16. Luteolin inhibits mast cell-mediated allergic inflammation.
Kritas SK; Saggini A; Varvara G; Murmura G; Caraffa A; Antinolfi P; Toniato E; Pantalone A; Neri G; Frydas S; Rosati M; Tei M; Speziali A; Saggini R; Pandolfi F; Cerulli G; Theoharides TC; Conti P
J Biol Regul Homeost Agents; 2013; 27(4):955-9. PubMed ID: 24382176
[TBL] [Abstract][Full Text] [Related]
17. Vigna angularis inhibits mast cell-mediated allergic inflammation.
Kim HH; Kim SW; Kim DS; Oh HM; Rho MC; Kim SH
Int J Mol Med; 2013 Sep; 32(3):736-42. PubMed ID: 23828310
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway.
Bissonnette EY; Enciso JA; Befus AD
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):275-82. PubMed ID: 9070612
[TBL] [Abstract][Full Text] [Related]
19. Ripe fruit of Rubus coreanus inhibits mast cell-mediated allergic inflammation.
Kim HH; Choi PH; Yoo JS; Jeon H; Chae BS; Park JS; Kim SH; Shin TY
Int J Mol Med; 2012 Feb; 29(2):303-10. PubMed ID: 22075758
[TBL] [Abstract][Full Text] [Related]
20. Cornuside inhibits mast cell-mediated allergic response by down-regulating MAPK and NF-κB signaling pathways.
Li L; Jin G; Jiang J; Zheng M; Jin Y; Lin Z; Li G; Choi Y; Yan G
Biochem Biophys Res Commun; 2016 Apr; 473(2):408-14. PubMed ID: 26972254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
